Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Testosterone 40.5mg/2.5g transdermal gel unit dose sachets |
| BNF code | 0604020K0AABSBS |
| Virtual Therapeutic Moiety | Testosterone |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 3 Oct 2023 |
| Previous name | Testosterone 40.5mg/2.5g gel unit dose sachets |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | sachet |
| Unit dose unit of measure | sachet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Testosterone |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 40.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | gel.transdermal |
| Dose Form | |
| Formulation | Transdermal gel |
| Drug Route | |
| Route | Transdermal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 4 (CD Anab) |
| Actual Medicinal Products | |
| Testogel 40.5mg/2.5g transdermal gel sachets (Besins Healthcare (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Testosterone 40.5mg/2.5g transdermal gel unit dose sachets 30 sachet | |
dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.